BRIEF-Corcept Says US Court Rules Teva's Generic Korlym Does Not Infringe Corcept PatentsFeb 19 (Reuters) - Corcept Therapeutics Inc CORT.O:
CORCEPT PROVIDES UPDATE ON PATENT DISPUTE WITH TEVA PHARMACEUTICALS
CORCEPT THERAPEUTICS INC - RULING AFFIRMS DECEMBER 2023 VERDICT BY FEDERAL DISTRICT COURT
CORCEPT THERAPEUTICS INC - US COURT RULES TEVA'S GENERIC KORLYM DOES NOT INFRINGE CORCEPT PATENTS
CORCEPT THERAPEUTICS INC - CONSIDERING JUDICIAL REVIEW OF COURT DECISION
Source text: ID:nBwbVM1cFa
Further company coverage: CORT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments